Non-communicable diseases (NCDs), including cardiovascular diseases (CVD), hypertension and diabetes together with HIV infection are among the major public health concerns worldwide. Health services for HIV and NCDs require health systems that provide for people's chronic care needs, which present an opportunity to coordinate efforts and create synergies between programs to benefit people living with HIV and/or AIDS and NCDs. This review included studies that reported service integration for HIV and/or AIDS with coronary heart diseases, chronic CVD, cerebrovascular diseases (stroke), hypertension or diabetes. We searched multiple databases from inception until October 2015. Articles were screened independently by two reviewers and assessed for risk of bias. 11,057 records were identified with 7,616 after duplicate removal. After screening titles and abstracts, 14 papers addressing 17 distinct interventions met the inclusion criteria. We categorized integration models by diseases (HIV with diabetes, HIV with hypertension and diabetes, HIV with CVD and finally HIV with hypertension and CVD and diabetes). Models also looked at integration from micro (patient focused integration) to macro (system level integrations). Most reported integration of hypertension and diabetes with HIV and AIDS services and described multidisciplinary collaboration, shared protocols, and incorporating screening activities into community campaigns. Integration took place exclusively at the mesolevel, with no micro-or macro-level integrations described. Most were descriptive studies, with one cohort study reporting evaluative outcomes. Several innovative initiatives were identified and studies showed that CVD and HIV service integration is feasible. Integration should build on existing protocols and use the community as a locus for advocacy and health services, while promoting multidisciplinary teams, including greater involvement of pharmacists. There is a need for robust and well-designed studies at all levels -particularly macro-level studies, research looking at long-term outcomes of integration, and research in a more diverse range of countries.
Introduction
Non-communicable diseases, including cardiovascular diseases (CVD), hypertension and diabetes together with HIV infection are among the leading contributors to the global burden of disease (GBD 2013 Mortality and Causes of Death Collaborators, 2014; WHO, 2013) . The CVD burden is greatest in low and middleincome countries, where treatment is largely unaffordable or unavailable (Rasha, McKee, Shannon, Chow, & Rangarajan, 2016; WHO, 2013; Yusuf, Wood, Ralston, & Reddy, 2015) . It is estimated that over 700 million adults worldwide will be diagnosed with diabetes by 2025; increasingly and disproportionately in low and middle-income countries, which lack affordable and available essential medicines (NCD-RisC, 2016; WHO, 2016) . HIV, despite decreases in overall new infections globally, remains a major threat among vulnerable groups worldwide and particularly in parts of Africa; nearly half of new HIV infections are people living in Nigeria, South Africa and Uganda, where HIV and AIDS is the greatest cause of life-years lost (Collaborators, 2016; Piot, Abdool Karim, Hecht, & Legido-Quigley, 2015) . Consequently, many countries are now coping with the dual burden of HIV and NCDs (UNAIDS, 2011) . People living with HIV are living longer and are at greater risk of developing NCDs for various reasons, including the direct consequence of HIV infection, shared risk factors and treatment side effects (UNAIDS, 2011) .
Health systems, particularly in low-income countries, are often ill prepared to identify at risk patients and ensure life-long care (Rabkin, Melaku, & Bruce, 2012) . However, given that HIV and NCDs have common chronic care needs, there is an opportunity to coordinate efforts and achieve synergies to benefit patients (Haregu, Setswe, Elliott, & Oldenburg, 2015) . Although such integration is intuitively appealing, relatively little is known about integration models and factors that facilitate or hinder integration in different contexts. To address this gap, we systematically reviewed the literature examining programs or services integrating diabetes, hypertension or CVDs with HIV and AIDS, reporting outcomes where available, exploring barriers and facilitators to integration, and making recommendations for future research and policy.
Methods
This review was developed according to PRISMA guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009 ) and is part of a larger systematic review of service integration for HIV and other conditions. Where possible, we follow the PICOS structure. Drawing on definitions proposed by Briggs and Garner (2006) , Atun, de Jongh, Secci, Ohiri, and Adeyi (2010) and Legido-Quigley et al. (2013) as well as a dimension of integration typology, the concept of integration is described in Box 1 Curry & Ham, 2010; WHO, 2008) .
Box 1. Definition of integration.
Managerial or operational changes to health systems to bring together inputs, delivery, management and organization of particular service functions as a means of improving coverage, access, quality, acceptability and (cost)-effectiveness. This may include: Service integrations that combine "different packages of services"
• Integration of service delivery points • Integration at different levels of service delivery • Process modifications • Introduction of technologies aimed at aiding integration • Integration of management decisions
Inclusion criteria
We included studies reporting programs that integrated HIV with CVDs and their risk factors (hypertension or type 2 diabetes mellitus) coronary heart disease, or cerebrovascular diseases (stroke). We included all studies, both in health facilities or the community, that reported on the effects of integrated HIV and AIDS and chronic disease services, including screening and/or treatment, using quantitative, qualitative and mixed methods. We also included reports of patient's perspectives on integrations. We did not exclude reports based on study design; nor did we require them to include outcome measures. There were no date or language restrictions.
Search strategy
We developed a search strategy with an information specialist (Box 2 3. (All introduced in a separate line) chronic disease/ or long-term care/ or ((chronic* or persistent or long* term or ongoing or degenerative) adj3 (disease* or disab* or ill* or condition* or health condition* or medical condition*)).tw. Or long* term care.tw. Or (noncommunicable disease* or NCD).tw. Or exp diabetes mellitus/ or (diabetes or diabetic).tw. Or exp hypertension/ or (hypertension or high blood pressure).tw. Or exp cerebrovascular disorders/ or (cerebrovascular disease* or cerebrovascular disorder* or brain ischaemia or cerebral infarction or carotid artery disease* or stroke).tw. Or exp dementia/ or (dementia or alzheimer*).tw. Or exp epilepsy/ or epilep*.tw. Or exp myocardial ischemia/ or (myocardial isch* or ischaemic heart disease or ischemic heart disease or angina or coronary disease* or coronary heart disease* or coronary artery disease* or myocardial infarction).tw. Or exp heart failure/ or heart failure.tw. Or exp obesity/ or (obesity or obese).tw.
4. 1 and 2 and 3.
Search and retrieval of studies
Two reviewers independently reviewed the retrieved article list to identify relevant articles, based on title or title and abstract. Two reviewers independently assessed the retrieved articles to determine whether they met inclusion criteria. Any disagreements were resolved by discussion with a third reviewer.
Data synthesis
Two reviewers independently extracted study characteristics and results data using standardized forms. Differences were resolved by discussion and consensus. Due to the heterogeneity in study design, intervention types and outcomes, we did not conduct a meta-analysis, but instead present a narrative synthesis and, where available, report outcomes.
Levels of integration
We defined integration levels and types based on integrated care typologies (Curry & Ham, 2010) . This typology differentiated integration at the micro-level as patient focused, such as case management, whereas meso-level integration focused on groups, such as screening, and macro-level integrated larger systems. Within these levels, the typology distinguishes integration types; we classify clinical integration as care integrated into a single process through shared guidelines and protocols across professions, and service integration as different clinical services integrated within an organization and provided through multidisciplinary teams.
Risk of bias assessment
Two reviewers independently assessed studies which present evaluative data for risk of bias using the Cochrane risk of bias tool for randomized studies, an adapted checklist for qualitative studies and a simple proforma for observational descriptive studies (Oliver et al., 2008; Rees et al. 2006 ). This proforma included three domains: selection bias, information bias and confounding. Each domain was assessed as low, unclear or high.
Results 11,057 records were identified with 7,616 remaining after duplicate removal. These were screened by title and abstract for inclusion. Of 340 assessed for eligibility, 153 studies were included in full-text screening. Of these, 138 were ineligible, resulting in 14 articles included. These 14 articles represent 17 studies that met eligibility criteria for this review ( Figure 1 ).
Models of integration
We identified four integrated care models defined by conditions integrated; integration services took place in various settings and involved screening, referral and treatment activities, as well as training and procedure development Of 17 studies, seven took place in community/mobile locations (Chamie et al., 2012; Inouye et al., 2011; Kotwani et al., 2014; Tiam et al., 2012; Tierney et al., 2011; UNAIDS, 2011) ; and five at HIV clinics (Bury et al., 2007; Monroe et al., 2012; Namata et al., 2014; Nyabera et al., 2011; UNAIDS, 2011) (Table 1) . The majority of studies reported were program descriptions (n = 12) ( Table 2) . Integrations were reported entirely at the meso-level (Table 3) .
Model 1: integrating diabetes services with HIV and AIDS services Three studies integrated diabetes services into HIV services (Adeyemi et al., 2009; Bury et al., 2007; UNAIDS, 2011) . Study design, integration activities and results are reported fully in Appendix 1.
Two studies reported clinical outcomes, assessed as meeting goals set by the American Diabetes Association (ADA); One study reported on diabetes treatment provision to 40 patients in an HIV clinic in the U.S., finding that most patients achieved almost undetectable viral load and CD4 cell counts of 460 to 480 cells/μL and yet, less than 50% of patients achieved ADA goals (Bury et al., 2007) . However, a record review of 216 patients with diabetes at an HIV clinic in the USA, found that 54% of patients met HbA1c goals (Adeyemi et al., 2009) . These outcomes were reported as comparable with those amongst HIV negative persons. The authors suggest pharmacists could support patient education and advise other health professionals (Adeyemi et al., 2009 ). The case study from Ethiopia described HIV material adaptation for use in diabetes care at a diabetes outpatient clinic, as well as staff and peer training and multidisciplinary team meetings. The program reported an increase in the percentage of people receiving diabetes services (UNAIDS, 2011).
Model 2: integrating hypertension and diabetes services with HIV and AIDS services Eight studies integrated diabetes and hypertension services with HIV and AIDS services (Chamie et al., 2012; Edwards et al., 2015; Kotwani et al., 2014; Monroe et al., 2012; Noble et al., 2012; Tiam et al., 2012; UNAIDS, 2011) . Study design, integration activities and results are reported fully in Appendix 1.
Three studies reported clinical outcomes. A program in Cambodia piloted integrated HIV, hypertension and diabetes care using a patient-centered case management approach (UNAIDS, 2011). The program reported high retention rates, increase in CD4 counts, decrease in median HbA1c and target blood pressure attainment amongst hypertensive patients (UNAIDS, 2011). A retrospective record review in Kenya described introduction of an NCD program into a primary health care setting and found blood pressure improvement and comparable diabetes outcomes among those with and without HIV (Edwards et al., 2015) . A study from a hypertension clinic in the U.K. provided 36 patients with lifestyle advice, cardiovascular risk assessment and screening for diabetes and reported blood pressure reductions, with 63% of patients achieving their target (Noble et al., 2012) .
Other studies reported increased screening uptake but mixed results for subsequent referral. A mobile screening initiative in Lesotho reached 8,396 adults for HIV testing and found amongst those testing HIV positive, 36.6% enrolled in further HIV care; 4,434 adults underwent hypertension screening, of whom 24.2% had elevated blood pressure and received treatment; and 3,045 blood sugar tests were conducted, finding 3.1% participants to have elevated blood sugar and referring them on (Tiam et al., 2012) . Campaigns offering preventive, treatment and referral services in Uganda reportedly reached upwards of 74% of adults; among newly detected HIV cases, 39% were referred and linked to care, but within a subgroup with CD4 < 100, 83% linked to care and started ART within 10 days; 43% of newly diagnosed hypertensive patients and 61% of newly diagnosed diabetics were linked to care (Chamie et al., 2012) . Another campaign from Uganda described a hypertension testing and referral program and reported promising results for linkage to care: amongst 2,252 people screened, 214 had hypertension and received care, 83% of these within 6 months; however, the remainder forwent follow-up for various reasons including transport cost and feeling better (Kotwani et al., 2014) .
One study explored patient perspectives with focus groups at an HIV clinic in Baltimore, USA (Monroe et al., 2012) . The study discussed barriers to comorbidity treatment, patients viewed comorbidities as a greater threat than HIV and expressed frustration at lack of control over them (Monroe et al., 2012) . Patients also described the perceived ineffectiveness of comorbidity medication and lack of consequences following missed doses, as well as the importance of social support in adherence.
Model 3: integrating CVD services with HIV and AIDS services Three studies integrated CVD risk factor evaluation (high BMI, age and sex) with HIV and AIDS services. Study design, integration activities and results are reported fully in Appendix 1.
One abstract from Nigeria integrated CVD screening into HIV services in a clinic where 1,033 patients were randomly selected for screening. The study found nearly 20% of those screened had one or more CVD risk factor, concluding that screening integration was feasible and necessary (Gwarzo et al., 2012) . One study described a program to train healthcare providers, provide screening equipment and establish referral pathways in HIV facilities in Kenya (Nyabera et al., 2011) . The study found that CVD service operationalization in an HIV setting was feasible, with high staff acceptance and skills uptake; however, noted that 1/3 of available CVD equipment was not in serviceable condition (Nyabera et al., 2011) . Another study from Kenya, sought to explore HIV and CVD service integration and reported the need for 
hypertension screening amongst people living with HIV (UNAIDS, 2011).
Model 4: integrating diabetes, hypertension and CVD services with HIV and AIDS services
Three studies integrated diabetes, hypertension, CVD and other services into HIV and AIDS service delivery. Study design, integration activities and results are reported fully in Appendix 1. A study from Uganda described an integrated NCD program introducing new data collection and recording methods using existing HIV structures and reported improved NCD diagnosis, tracking and management within HIV care (Namata et al., 2014) . One study reported on a community health worker-led referral initiative for community screening in Kenya; the initiative has reached 454,598 persons, of whom 96% were screened for HIV, and is now expanding to provide hypertension and diabetes screening (Tierney et al., 2011) . The study reports challenges linking to care, with only 17% of cases visiting affiliated clinics. Another study described a culturally sensitive approach for interventions for HIV, diabetes and COPD in Asian and Pacific Island populations in Hawaii, USA and reported the importance of interdisciplinary approaches and collaboration (Inouye et al., 2011) .
Outcomes reported
Studies reported both clinical and descriptive outcomes (Table 4) . Clinical outcomes included improvements in blood pressure, hemoglobin A1c (HbA1c), cholesterol levels and CD4 count. Descriptive outcomes included process improvements, staff acceptance and patient satisfaction.
Risk of bias assessment & measures of effectiveness of integration
After screening we identified one evaluative study eligible for risk of bias assessment (Bury et al., 2007) . This study had moderate risk of selection bias due to small sample size and high performance bias due to non-blinding. The same study reported on measures of effectives of integration and sought to evaluate whether seeing a clinical pharmacist improved diabetes outcomes; however, there was no statistically significant difference between groups (Bury et al., 2007) .
Discussion
The four models described seek to integrate HIV and AIDS services with diabetes, hypertension and/or CVD services through interventions and campaigns. The first model integrates diabetes services into HIV and AIDS services through diabetes service provision at HIV clinics, as well as through adaptation of HIV protocols for NCD use. The second model, comprising the most studies, goes a step further and integrates hypertension and diabetes care, with HIV and AIDS services. There were relatively fewer studies under the third model of CVD and HIV integrations, or the fourth model, which integrated HIV and AIDS services with diabetes, hypertension and CVD.
A common finding across models was using existing HIV infrastructure to both create NCD protocols and facilitate integration. Primarily in low-income countries with a high burden of HIV, these systems provide a platform for collaboration, staff training and acceptance in introducing NCD care. Further, community campaigns, health fairs and mobile service points offered scope for delivering screening and referral services; however, there ensues challenges in ensuring referral and followup. In high-income countries, data suggest that integrating diabetes with HIV services is feasible, with dedicated clinical pharmacists playing an important role.
These models have advantages and disadvantages ( Table 5 ). Integrations that provide screening only, have potential to increase case detection and provide patient education; however, screening requires appropriate training, equipment, cultural sensitivity and a supportive referral system (Inouye et al., 2011; Namata et al., 2014; Tierney et al., 2011) . Integrations that incorporate treatment may be better able to address patients' multiple needs and can leverage on existing services, yet these integrations may introduce competing demands on providers or exclude other NCDs (Nyabera et al., 2011) . Further, there is a need for leadership at the service delivery level to catalyze change and drive integration of NCDs with HIV service provision (UNAIDS, 2011).
Study strengths and limitations
Our review benefits from the inclusion of a range of databases and conference archives, which increased the representation from low-and middle-income countries. The review also included studies published in languages other than English. A limitation of our review is the majority of descriptive papers, which while providing insight on strategies and approaches are unable to reveal program effectiveness. As a result, this review is highly descriptive.
Implications for research
Our review found the majority of research integrating CVD, hypertension and diabetes with HIV and AIDS focuses on incorporating NCD care into existing HIV care. This resonates with the recommendation that the NCD movement can leverage on existing HIV and AIDS activities (Jay et al., 2016; Rabkin & El-Sadr, 2011) . Studies mainly describe small-scale interventions carried out in conjunction with other clinic or community activities. There is a need for evidence on integration effectiveness and research into integrations at the micro and macro-level. As the longest follow-up reported was 6 months, there is also need to explore long-term integration outcomes. Further, no papers described incentive use, revealing a need to explore if and what type would be appropriate in facilitating greater service integration.
The evidence from our review shows that integration studies on HIV and CVD services are occurring largely in low income countries in Sub-Saharan Africa and through channels relying on existing HIV and AIDS care infrastructure. With a growing intersection of persons with HIV and NCDs in low-and middle-income countries, there is a need to evaluate integrated service types that are most effective in these settings (Yusuf et al., 2015) . Further, thirteen studies were from Sub -Saharan Africa, only one study was from Asia and there were no studies from Latin America, highlighting the need for further research in these regions.
Conclusions
Several innovative initiatives have been described for integrating CVD, hypertension and diabetes services with HIV and AIDS services. These highlight the importance of using communities as a locus of action for activism, advocacy, accountability and service delivery; the importance of partnerships to facilitate multidisciplinary collaborations; as well as the need for robust evidence and research to evaluate advances in practice and treatment. The need for robust research speaks to the greater need for initiatives that bring people living with HIV into mainstream NCD services. As the burden of NCDs increases and persons with HIV live longer, policy makers and planners need to plan for the increasing number of people with multiple conditions and evaluate best strategies to provide care.
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UK -in-reach HT clinic n = 36
Cross Sectional Survey HIV patients were given appropriate lifestyle advice, underwent full cardiovascular risk assessment and screening for diabetes.
44% patients referred for echocardiogram, 43% of these showed an abnormality .Antihypertensive medications were introduced or changed in 85% of patients .BP reduction seen in most patients attending the clinic with 63% achieving their target BP .The average decrease seen in the 10-year cardiovascular risk was 39% with a range of 8% to 74% .All patients rated clinic as good or great on all aspects and were happy with the care they were receiving.
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Appendix 1: Summary of findings of studies examining integration of HIV with diabetes, hypertension and CVD.
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